InfuSystem Holdings, Inc. (INFU)
NYSEAMERICAN: INFU · Real-Time Price · USD
12.04
-0.02 (-0.17%)
Aug 28, 2026, 4:00 PM EDT - Market closed
InfuSystem Holdings Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 143.34 | 143.44 | 134.86 | 125.79 | 109.91 | 102.38 |
Revenue Growth | 2.47% | 6.36% | 7.22% | 14.44% | 7.36% | 5.99% |
Gross Profit Gross Profit Growth | 82.35 | 80.3 | 70.4 | 63.11 | 60.56 | 58.54 |
Operating Income Operating Income Growth | 11.27 | 10.92 | 7.49 | 4.09 | 1.65 | 2.82 |
Net Income Net Income Growth | 8.54 | 6.63 | 2.35 | 0.87 | 0.02 | 1.42 |
Earnings Per Share EPS Growth | 0.40 | 0.31 | 0.11 | 0.04 | 0.00 | 0.06 |
EPS Growth | 68.89% | 181.82% | 175.01% | 4690.30% | -98.61% | -92.50% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Device Solutions Device Solutions Growth | 59.2 | 64.1 | 61.74 | 55.83 | 47.51 | 42.54 |
Elimination of Inter-Segment Revenues Elimination of Inter-Segment Revenues Growth | -7 | -7.19 | -7.25 | -6.58 | -6.47 | -5.75 |
Patient Services Patient Services Growth | 91.13 | 86.53 | 80.38 | 76.54 | 68.88 | 65.6 |
Total Total Growth | 143.34 | 143.44 | 134.86 | 125.79 | 109.91 | 102.38 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 0.96 | 3.19 | 0.53 | 0.23 | 0.17 | 0.19 |
Total Debt Total Debt Growth | 24.53 | 24.44 | 28.42 | 34.9 | 36.92 | 36.77 |
Net Cash (Debt) Net Cash Growth | -23.57 | -21.25 | -27.9 | -34.67 | -36.75 | -36.58 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.13 | -1.01 | -1.29 | -1.60 | -1.71 | -1.66 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 23.37 | 24.41 | 20.46 | 11.22 | 17.52 | 18.32 |
Capital Expenditures CapEx Growth | -10.82 | -8.69 | -17.83 | -11.12 | -15.08 | -16.66 |
Free Cash Flow Free Cash Flow Growth | 12.55 | 15.72 | 2.63 | 0.11 | 2.44 | 1.66 |
Free Cash Flow Growth | -6.21% | 498.70% | 2377.36% | -95.66% | 47.05% | -50.68% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 57.45% | 55.98% | 52.20% | 50.17% | 55.10% | 57.17% |
Operating Margin | 7.86% | 7.61% | 5.56% | 3.25% | 1.50% | 2.75% |
Pretax Margin | 8.52% | 7.41% | 3.75% | 1.47% | 0.12% | 1.23% |
Profit Margin | 5.96% | 4.62% | 1.74% | 0.69% | 0.02% | 1.39% |
FCF Margin | 8.76% | 10.96% | 1.95% | 0.08% | 2.22% | 1.62% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 30.04 | 27.53 | 76.62 | 256.05 | 9960.96 | 247.65 |
Forward PE | 24.91 | 27.02 | 37.01 | 105.40 | 66.77 | 83.07 |
P/FCF Ratio | 19.11 | 11.60 | 68.42 | 2106.36 | 73.45 | 211.84 |
PS Ratio | 1.67 | 1.27 | 1.33 | 1.78 | 1.63 | 3.44 |